Why is Venmax Drugs falling/rising?

As of 06-Oct, Venmax Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 19.22, reflecting a decrease of 0.93 or 4.62%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total drop of 9.13% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The stock's delivery volume has also significantly decreased, with an 88.63% drop compared to the 5-day average, suggesting falling investor participation. There is no information available regarding positive or negative factors that could influence the stock's recent movement.
Broader market context shows that Venmax Drugs has underperformed against the benchmark Sensex, which has gained 1.77% over the past week while Venmax has declined by 13.58%. In the last month, the stock has dropped 22.19%, contrasting with the Sensex's modest gain of 1.34%. This stark difference in performance highlights the stock's struggles in the current market environment, further exacerbated by its recent price movements and declining trading activity.